Korea wins U.S. patent for recombinant anthrax vaccine

The country's public health and safety agency had won an U.S. patent for the process of manufacturing a recombinant anthrax vaccine, the Korea Centers for Disease Control and Prevention (KCDC) said Tuesday.

The patent, was jointly filed to the U.S. Patent Office by the KCDC and Green Cross Corp. in January 2011, relates to the method of expressing the protective antigen (PA) of Bacillus anth...